Gene Name |
splA/ryanodine receptor domain and SOCS box containing 2 |
nitric oxide synthase 2, inducible |
Image |
|
|
Gene Ontology Annotations |
Cellular Component |
|
|
Molecular Function |
|
|
Biological Process |
|
|
Pathways |
|
|
Drugs |
|
- L-Arginine
- L-Citrulline
- Miconazole
- Dexamethasone
- N,N-dimethylarginine
- 4r-Fluoro-N6-Ethanimidoyl-L-Lysine
- 3-Bromo-7-Nitroindazole
- N-(3-(Aminomethyl)Benzyl)Acetamidine
- 7-Nitroindazole
- Ethylisothiourea
- Thiocoumarin
- Aminoguanidine
- S-Ethylisothiourea
- N-Omega-Propyl-L-Arginine
- (6r,1\'r,2\'s)-5,6,7,8 Tetrahydrobiopterin
- Heme
- 6-Nitroindazole
- N-Omega-Hydroxy-L-Arginine
- 7,8-Dihydro-L-Biopterin
- N-(4-(2-((3-Chlorophenylmethyl)Amino)Ethyl)Phenyl)-2-Thiophecarboxamidine
- L-Thiocitrulline
- 7,8-Dihydrobiopterin
- 5-Nitroindazole
- 5-(4\'-AMINO-1\'-ETHYL-5\',8\'-DIFLUORO-1\'H-SPIRO[PIPERIDINE-4,2\'-QUINAZOLINE]-1-YLCARBONYL)PICOLINONITRILE
- N-[2-(1,3-BENZODIOXOL-5-YL)ETHYL]-1-[2-(1H-IMIDAZOL-1-YL)-6-METHYLPYRIMIDIN-4-YL]-D-PROLINAMIDE
- 4-({4-[(4-methoxypyridin-2-yl)amino]piperidin-1-yl}carbonyl)benzonitrile
- (2S)-2-methyl-2,3-dihydrothieno[2,3-f][1,4]oxazepin-5-amine
- (3R)-3-[(1,2,3,4-tetrahydroisoquinolin-7-yloxy)methyl]-2,3-dihydrothieno[2,3-f][1,4]oxazepin-5-amine
- 4-(1,3-BENZODIOXOL-5-YLOXY)-2-[4-(1H-IMIDAZOL-1-YL)PHENOXY]PYRIMIDINE
- (3S)-1-(1,3-BENZODIOXOL-5-YLMETHYL)-3-[4-(1H-IMIDAZOL-1-YL)PHENOXY]PIPERIDINE
- 4-(1,3-BENZODIOXOL-5-YLOXY)-2-[4-(1H-IMIDAZOL-1-YL)PHENOXY]-6-METHYLPYRIMIDINE
- ETHYL 4-[(4-CHLOROPYRIDIN-2-YL)AMINO]PIPERIDINE-1-CARBOXYLATE
- N-[2-(4-AMINO-5,8-DIFLUORO-1,2-DIHYDROQUINAZOLIN-2-YL)ETHYL]-3-FURAMIDE
- ETHYL 4-[(4-METHYLPYRIDIN-2-YL)AMINO]PIPERIDINE-1-CARBOXYLATE
- N-[2-(6-AMINO-4-METHYLPYRIDIN-2-YL)ETHYL]-4-CYANOBENZAMIDE
- 1-(6-CYANO-3-PYRIDYLCARBONYL)-5\',8\'-DIFLUOROSPIRO[PIPERIDINE-4,2\'(1\'H)-QUINAZOLINE]-4\'-AMINE
- 4-(1H-IMIDAZOL-1-YL)PHENOL
- 1-[4-(AMINOMETHYL)BENZOYL]-5\'-FLUORO-1\'H-SPIRO[PIPERIDINE-4,2\'-QUINAZOLIN]-4\'-AMINE
- Triflusal
|
Diseases |
|
|
GWAS |
|
|
Protein-Protein Interactions |
6 interactors:
APP
DDX4
GALNT15
NOS2
PAWR
PRMT1
|
11 interactors:
ACTB
ACTN4
CAV1
PEX5
RAC1
RAC2
SLC9A3R1
SPSB1
SPSB2
SPSB4
SRC
|
Entrez ID |
84727 |
4843 |
HPRD ID |
13610 |
01225 |
Ensembl ID |
ENSG00000111671
|
ENSG00000007171
|
Uniprot IDs |
B7Z4W1
Q99619
|
P35228
|
PDB IDs |
3EMW
|
1NSI
2LL6
2NSI
3E7G
3EJ8
3HR4
4NOS
|
Enriched GO Terms of Interacting Partners? |
|
|
Tagcloud ? |
|
17q
2q35
5p
6p
9p
bcg
candidates
demonstration
dichotomy
exacerbation
examines
helper
histocompatibility
il4
immunology
inbred
ity
leishmania
leishmanial
leishmaniasis
lsh
mexicana
mip1
nramp1
parasites
pleiotropic
positionally
reflecting
sigje
|
Tagcloud (Difference) ? |
|
17q
2q35
5p
6p
9p
bcg
candidates
demonstration
dichotomy
exacerbation
examines
helper
histocompatibility
il4
immunology
inbred
ity
leishmania
leishmanial
leishmaniasis
lsh
mexicana
mip1
nramp1
parasites
pleiotropic
positionally
reflecting
sigje
|
Tagcloud (Intersection) ? |
|